Franklin Resources’s Cullinan Oncology CGEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$771K Buy
+42,345
New +$629K ﹤0.01% 2397
2025
Q4
Sell
-1,416,036
Closed -$8.4M 3144
2025
Q3
$8.4M Sell
1,416,036
-812,124
-36% -$5.95M ﹤0.01% 1222
2025
Q2
$16.8M Buy
2,228,160
+8,399
+0.4% +$67.5K ﹤0.01% 975
2025
Q1
$16.8M Buy
2,219,761
+20,052
+0.9% +$192K ﹤0.01% 952
2024
Q4
$26.8M Buy
2,199,709
+8,447
+0.4% +$121K 0.01% 811
2024
Q3
$35.6M Sell
2,191,262
-252,868
-10% -$4.49M 0.01% 701
2024
Q2
$42.6M Sell
2,444,130
-252,632
-9% -$5.38M 0.01% 595
2024
Q1
$46M Sell
2,696,762
-584,518
-18% -$9.03M 0.01% 596
2023
Q4
$33.4M Buy
3,281,280
+390,505
+14% +$3.46M 0.02% 623
2023
Q3
$26.2M Buy
2,890,775
+556,689
+24% +$5.8M 0.01% 669
2023
Q2
$25.1M Buy
2,334,086
+1,544,948
+196% +$16.4M 0.01% 707
2023
Q1
$8.07M Buy
789,138
+7,012
+0.9% +$77.3K ﹤0.01% 977
2022
Q4
$8.25M Sell
782,126
-3,093
-0.4% -$37.6K ﹤0.01% 987
2022
Q3
$10.1M Buy
785,219
+6,137
+0.8% +$82.7K 0.01% 928
2022
Q2
$9.99M Buy
779,082
+1,202
+0.2% +$13.6K 0.01% 955
2022
Q1
$8.14M Buy
777,880
+3,346
+0.4% +$45.2K ﹤0.01% 1065
2021
Q4
$12M Sell
774,534
-1,872
-0.2% -$37.3K ﹤0.01% 1009
2021
Q3
$17.5M Sell
776,406
-1,092
-0.1% -$29.2K 0.01% 920
2021
Q2
$20M Buy
777,498
+289,190
+59% +$8.89M 0.01% 855
2021
Q1
$20.3M Buy
+488,308
New +$19.8M 0.01% 833

Other funds holding CGEM

Franklin Resources's CGEM Position: Q2 2026 in Review

Franklin Resources opened a new position in Cullinan Oncology (CGEM) in Q2 2026: 42,345 shares worth $771K. The stake represents ﹤0.01% of the portfolio and ranks #2397 among its holdings. This is a return to the name: Franklin Resources previously reported a position in CGEM as recently as Q3 2025.

Franklin Resources first reported a position in CGEM in Q1 2021 and has held it in 20 quarters since. The position peaked at $46M in Q1 2024. 121 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Franklin Resources held 42,345 shares of Cullinan Oncology worth $771K as of Q2 2026.
  • Cullinan Oncology was a new Franklin Resources position in Q2 2026.
  • Cullinan Oncology made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2397 holding.
  • Franklin Resources first reported a position in Cullinan Oncology in Q1 2021 and has held it in 20 quarters since.
  • Franklin Resources's Cullinan Oncology position peaked at $46M in Q1 2024.
  • 121 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.